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Abstract: Signaling pathways that originate at the plasma membrane, including regulated intramem-
brane proteolysis (RIP), enable extracellular cues to control transcription. We modified the yeast Gal4
transcription system to study the nuclear translocation of transcriptionally active complexes using the
fluorescent protein citrine (Cit) as a reporter. This enabled highly sensitive quantitative analysis of tran-
scription in situ at the single cell level. The Gal4/UAS-Cit transcription assay displayed a sigmoidal
response limited by the number of integrated reporter cassettes. We validated the assay by analyzing
nuclear translocation of the amyloid precursor protein (APP) intracellular domain (AICD) and confirmed
the requirement of Fe65 for nuclear translocation of AICD. In addition to the strong on-off effects on
transcriptional activity, the results of this assay establish that phosphorylation modifies nuclear signaling.
The Y682F mutation in APP showed the strongest increase in Cit expression, underscoring its role in
regulating Fe65 binding. Together, we established a highly sensitive fluorescent protein-based assay that
can monitor transcriptional activity at the single cell level and demonstrate that AICD phosphorylation
affects Fe65 nuclear activity. This assay also introduces a platform for future single cell-based drug
screening methods for nuclear translocation.
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Abstract: Signaling pathways that originate at the plasma 
membrane, including regulated intramembrane proteoly-
sis (RIP), enable extracellular cues to control transcrip-
tion. We modified the yeast Gal4 transcription system to 
study the nuclear translocation of transcriptionally active 
complexes using the fluorescent protein citrine (Cit) as a 
reporter. This enabled highly sensitive quantitative anal-
ysis of transcription in situ at the single cell level. The 
Gal4/UAS-Cit transcription assay displayed a sigmoidal 
response limited by the number of integrated reporter 
cassettes. We validated the assay by analyzing nuclear 
translocation of the amyloid precursor protein (APP) 
intracellular domain (AICD) and confirmed the require-
ment of Fe65 for nuclear translocation of AICD. In addition 
to the strong on-off effects on transcriptional activity, the 
results of this assay establish that phosphorylation modi-
fies nuclear signaling. The Y682F mutation in APP showed 
the strongest increase in Cit expression, underscoring its 
role in regulating Fe65 binding. Together, we established 
a highly sensitive fluorescent protein-based assay that 
can monitor transcriptional activity at the single cell level 
and demonstrate that AICD phosphorylation affects Fe65 
nuclear activity. This assay also introduces a platform 
for future single cell-based drug screening methods for 
nuclear translocation.
Keywords: amyloid precursor protein; amyloid precur-
sor protein intracellular domain (AICD); Fe65; Gal4/UAS 
assay; nuclear translocation; regulated intramembrane 
proteolysis (RIP).
Introduction
Regulated intramembrane proteolysis (RIP) of trans-
membrane proteins by the γ-secretase complex releases 
the intracellular domains (ICDs) from the membrane. 
Subsequently, these ICDs can translocate to the nucleus 
to activate transcription, as originally shown for RIP of 
the Notch receptor (De Strooper et al., 1999). Exploration 
of nuclear signaling is achieved by microscope analy-
sis of nuclear translocation or subcellular fractionation 
of nuclei coupled to detection of the ICDs. To directly 
measure transcriptional activity, reporter systems consist-
ing of promoter sequences fused to enzymes that generate 
measurable signals have been used. In the case of Notch, 
where target genes are clearly identified, endogenous 
promoters of the genes can be fused to reporter enzymes. 
Identification and characterization of transcriptional 
activators with unknown target sequences is often done 
with the yeast-derived Gal4/UAS system (Kakidani and 
Ptashne, 1988). Herein, the Gal4 DNA-binding domain 
(Gal4-DBD) is fused to a protein of interest (POI). The Gal4-
DBD binds to an array of upstream activating sequences 
(UAS), leading to the expression of a downstream reporter 
gene if the POI has transcriptional activity. Frequently 
used reporter genes are β-galactosidase, which generates 
a color precipitate identifiable in a microscope, and lucif-
erase, which can be quantified using luminescence plate 
readers. Fluorescent protein reporters have mainly been 
used to study neuron morphology and connectivity using 
binary systems for targeted gene expression in Drosophila 
and zebrafish, where different Gal4 driver lines are com-
bined with a variety of different UAS-linked transgenes 
(Duffy, 2002; Scott, 2009).
None of the methodologies to investigate nuclear sign-
aling is without caveat. Antibody-based detection can be 
difficult in the nuclei of fixed cells, due to the dense packing 
of DNA, RNA, and proteins (Konietzko et al., 2010). There-
fore, the study of nuclear translocation often relies on 
fusing a fluorescent protein to the POI, which might alter 
its localization, metabolism, and function. When perform-
ing isolation of nuclei by subcellular fractionation, there 
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is inevitable contamination by the endoplasmic reticulum 
(ER) that is connected to the outer nuclear membrane. 
Thus, when studying nuclear signaling by transmembrane 
RIP substrates, there will be contamination by the full-
length proteins that are synthesized in the ER.
Analysis of transcriptional activity with the Gal4/UAS 
system is usually done by transient plasmid transfection 
of cell lines. The need to transfect multiple plasmids (i.e. 
reporter constructs, Gal4-DBD-fused transcription factors, 
further accessory proteins) results in varying combina-
tions of the individual plasmids in different cells. Fur-
thermore, with transient transfection, plasmids enter the 
cells via endocytosis, are released into the cytosol, and are 
transported toward the nucleus. Nuclear entry occurs only 
when the nuclear membrane breaks down during mitosis, 
unless the plasmids harbor a DNA nuclear targeting 
signal (Bai et al., 2017). This is not the case for the com-
monly used luciferase reporter plasmids. Hence, a vari-
able amount of transfected reporter plasmid enters the 
nucleus, depending on the replication rate of the cell line 
and the assay time post-lipofection. Furthermore, lucif-
erase assays employ lysis of the cells, mixing the subcellu-
lar compartments for varying times before readout. Taken 
together, transient transfection of multiple plasmids and 
lysis of cells for signal detection introduces variability that 
can obscure modulatory influences on plasma membrane 
to nucleus signaling and transcriptional activity.
Here, we developed a variant Gal4-based assay using 
the fluorescent protein citrine (Cit) as a reporter. We intro-
duced the reporter construct via lentiviral infection to 
generate cell lines with stable integration of the reporter 
in the genome. This ensures that the expression of Cit is 
regulated by bona fide nuclear translocation. After cell 
fixation, Cit fluorescence can be analyzed in situ without 
further processing. We developed the system for quantifi-
cation by either confocal microscopy or plate readers. The 
assay was applied to study nuclear signaling by the RIP 
substrate amyloid precursor protein (APP).
Results
Fluorescence readout for Gal4-dependent 
transcriptional activity
To establish a cellular assay for transcriptional activity 
that enables readout using microscopy we used the fluo-
rescent protein Cit to replace the commonly used luciferase 
or β-galactosidase reporters. For this, nine consecutive 
Gal4-binding sequences (9 × UAS) were placed upstream 
of the Cit cDNA (Figure 1A) and cloned into a pCCL-derived 
third-generation lentiviral vector. This lentiviral vector 
was used to generate HEK293 cells that harbor stable 
genomic integration of the reporter construct (HEK:UAS-
Cit). Transfection of reporter cells with the strong viral 
activator VP16 fused to a Gal4-DBD sequence (Gal4-VP16) 
revealed strong induction of Cit fluorescence by confocal 
microscopy (Figure 1B). Mock transfected reporter cells, in 
contrast, showed only weak fluorescence signal, indicat-
ing low reporter construct leakiness (Figure 1B). APP with 
a Gal4-DBD inserted internally, preceding the AICD (con-
tributed by Tom Südhof), was used to validate our assay 
system. APP-Gal4 alone caused a small, but significant 
increase in Cit fluorescence that was strongly enhanced 
by Fe65 co-expression (Figure 1B). For quantification, we 
measured the total Cit fluorescence and normalized it to 
the number of DAPI-stained nuclei (Figure 1C). The tran-
scriptional activity of APP, together with Fe65, reached 
approximately 15% of the activity of the strong viral acti-
vator VP16.
We observed that, in some cases, nuclei are not iden-
tified during the ImageJ analysis, i.e. when size or DAPI 
thresholding is outside of the set values for detection. Cit 
expressed by these cells will nevertheless be picked up 
with total Cit measurements. To enhance the accuracy of 
quantification, we fused three NLS to Cit, targeting it to 
the nucleus. Cit fluorescence was measured solely in the 
nucleus using the nuclear outline demarcated by DAPI 
staining, hence quantifying only nuclei that are counted 
for normalization (Figure 1D).
We infected HEK293 cells with reporter virus once 
(HEK1:UAS-Cit-NLS) and twice (HEK2:UAS-Cit-NLS). 
With the used virus titers of 107–108/ml supernatant, we 
assumed a 100% infection efficiency of HEK293 cells (105) 
and thus expected a maximum of approximately 100–1000 
or 200–2000 integrations per cell line, respectively (see 
the Materials and Methods). We titrated the Gal4-VP16-
expressing plasmid and saw a sigmoidal response of the 
Cit fluorescence signal, with the twice-infected cell line 
shifted to higher levels (Figure 1E). Titration of a plasmid 
directly expressing a nucleus-targeted fluorescent protein 
Cerulean (Cer)-NLS via a CMV promoter into HEK293 cells 
showed a non-saturated exponential increase in nuclear 
fluorescence over the same DNA concentration range 
(Figure 1F). This suggests that the Cit fluorescence signal 
observed with the Gal4-VP16-expression plasmid is caused 
by limited insertion sites of the UAS-Cit-NLS.
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Figure 1: Fluorescence readout for Gal4-dependent transcriptional activity.
(A) Scheme of the assay principle. The DBD is fused to a POI and transfected into cell lines that harbor lentivirus-mediated genomic 
integrations of nine consecutive upstream Gal4-binding sequences (9 × UAS), driving expression of the enhanced yellow fluorescent protein 
Cit. The transcriptional activity of the POI or associated proteins can be quantified by measuring Cit fluorescence. (B) Confocal microscopy 
images of a HEK:UAS-Cit cell line without treatment (ctrl) or transfected with Gal4-VP16, APP-Gal4, or APP-Gal4 together with Fe65. Numbers 
of DAPI-stained nuclei per frame are indicated. Scale bar: 200 µm. (C) Total Cit fluorescence was measured per frame and normalized to 
nuclei counts. Ten frames per condition were imaged from two different passages. Bars show mean ± SD. (D) Confocal microscopy images of 
a reporter HEK cell line expressing Cit-NLS transfected with Gal4-VP16. The DAPI-stained nuclear outline was determined with Fiji and used 
to measure the Cit signal solely in the nucleus. Scale bar: 100 µm. (E) DNA concentration series of Gal4-VP16 transfected into cells infected 
once (HEK1:UAS-Cit-NLS) or twice (HEK2:UAS-Cit-NLS) with the reporter virus expressing Cit-NLS. Quantification of nuclear Cit signal was 
performed on confocal microscopy images (n = 6 per concentration; shown as mean ± SD). The red dot on the y-axis denotes fluorescence 
of non-transfected cells. (F) DNA concentration series of Cer-NLS was transfected into wild-type HEK293 cells, and quantification was 
performed on confocal microscopy images (n = 6 per concentration; shown is mean ± SD). The red dot on the y-axis denotes fluorescence of 
non-transfected cells.
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APP-mediated nuclear signaling using 
microscopic inspection
For the analysis of AICD translocation to the nucleus, we 
again used the HEK2:UAS-Cit-NLS cell line (Figure  2A). 
To ensure measurement of the signals in the linear 
range, we adjusted the laser intensity and photon accu-
mulation accordingly (for details, see the Materials and 
Methods). We transfected the cells either with an empty 
vector (control) APP-Gal4 alone or together with Fe65, 
which caused a nearly 10-fold increase in the Cit signal 
(Figure 2A, B). Inhibition of APP cleavage by 1 µm DAPT 
(D) led to a strong reduction in the Cit signal. We also 
cloned an expression vector, encoding APP with a C-ter-
minal fusion of the Gal4-DBD (APP-Gal4ct). Notably, this 
construct caused only minor activity over the background 
in the presence of Fe65. Titration of the APP-Gal4 con-
struct together with Fe65 revealed a sigmoidal response 
with saturation of the reporter system at higher DNA con-
centrations, similar to the Gal4-VP16-induced Cit signal 
(Figure 2C). As inhibition of nuclear signaling by 1 µm 
DAPT did not completely block transactivation of the Cit 
reporter (Figure 2B), we analyzed a concentration series 
(0.56–10 µm) of DAPT inhibition. Increasing DAPT con-
centrations showed a dose-dependent decrease of the 
Cit signal with half-maximal inhibition at approximately 
2 µm DAPT (Figure 2D). To exclude DAPT toxicity through-
out the concentration series, we performed MTT assays, 
revealing no effect on cell viability (Figure 2E).
A variety of different adapter proteins have been shown 
to bind to AICD. We tested if other proteins, aside from 
Fe65, would support APP-Gal4-mediated Cit expression. 
Fe65 alone did not induce Cit expression because a Gal4-
DBD sequence is necessary to target transcriptional acti-
vators to the reporter sequences (Figure 2F). Together 
with APP-Gal4, we again detected a strong expression of 
Cit when Fe65 is co-expressed. In contrast, Mint1/X11 co-
expression did not reveal any transcriptional activation 
over the levels seen for APP-Gal4 alone. Co-expression of 
Jip1b significantly increased reporter gene expression, but 
to a much lower extent than that of Fe65. Equal protein 
abundance of HA-tagged Fe65, Mint1, and Jip1b was vali-
dated by staining the analyzed cells with anti-HA antibody 
and quantifying the total fluorescence (Figure 2G, H). The 
effect of the different adaptor proteins on APP levels was 
verified with Western blots (Figure 2I). Co-transfection of 
identical amounts of APP-Gal4 plasmid with the different 
APP-interacting proteins resulted in different APP levels 
as predicted from published data. Lowest full-length APP 
levels were seen with Fe65 that promotes APP turnover 
(Sabo et al., 1999), whereas Mint1/X11 and Jip1b, which are 
reported to stabilize full-length APP (Borg et al., 1998; Taru 
et  al., 2002), increased APP levels, both of endogenous 
APP and transfected APP-Gal4. Co-expression of Fe65 thus 
resulted in lowest APP-Gal4 levels, but this adapter protein 
induced the strongest expression of Cit.
APP-mediated nuclear signaling using plate 
reader analysis
We next analyzed the Gal4/UAS-Cit transcription assay 
using a fluorescence plate reader. To determine fluores-
cence signals due to leakage expression, we calculated 
Figure 2: Characterization of APP transcriptional activity.
(A) HEK2:UAS-Cit-NLS cells transfected with APP-Gal4 and Fe65. Confocal microscopy pictures on the left show the frames imaged for 
quantification. On the right, a fourfold magnification from part of the images is shown with the DAPI outline determined in Fiji. Scale bar: 
200 µm. (B) HEK2:UAS-Cit-NLS cells transfected with APP-Gal4 and GAL4 fusion to the C-terminus of AICD (APP-Gal4ct) with and without 
Fe65. Fe65 co-expressing cells were further treated with 1 µm DAPT (D). Cit fluorescence was determined with confocal microscopy. Ten 
frames were imaged per condition from two different passages. Bars show mean ± SD. (C) A cDNA concentration series of APP-Gal4 and 
Fe65 was used for transfection of HEK2:UAS-Cit-NLS cells and quantification was performed with confocal microscopy images (n = 6 frames 
per concentration for every of 3 passages; mean ± SD). The red dot on the y-axis denotes fluorescence of non-transfected cells. (D) Inhibition 
of γ-secretase with a DAPT concentration series in HEK2:UAS-Cit-NLS cells transfected with APP-Gal4 and Fe65. Quantification of nuclear Cit 
fluorescence shows dose-dependent inhibition (n = 6 frames per concentration for every of 3 passages; mean ± SD). The red dot on the y-axis 
denotes fluorescence of non-transfected cells. Green dot and SD denote the value of transfected cells without DAPT. (E) MTT assay reveals 
no toxicity of the DAPT concentration series. (F) Effects of different APP-interacting proteins, transfected into HEK2:UAS-Cit-NLS cells, on the 
transcriptional activity of APP-Gal4 quantified with confocal microscopy (n = 6 frames per lipofection for every passage of a total of 3; bars 
show mean ± SD). (G) Representative confocal microscope images of the experiment shown in (F) showing HA tag staining of the transfected 
APP-binding proteins. Scale bar: 200 µm. (H) Quantification of total fluorescence from the stained APP-binding proteins of the experiment 
shown in (F), normalized to the DAPI counts. (I) Western blot analysis with anti-APP antibody detecting endogenous APP and the transfected 
APP-Gal4. Low exposure shows only a faint band of endogenous mature APP that is superimposed by the immature and mature APP-Gal4 
bands, which run higher due to the approximately 20-kDa Gal4-DBD, while endogenous immature APP can still be resolved. Increased 
immature APP levels were detected upon co-expression of Mint1 or Jip1b as compared to Fe65.
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the LoB (Armbruster and Pry, 2008), as described in the 
Materials and Methods section, and subtracted this value 
from those of the experimental measurements. As with 
the results of confocal microscopy analysis (Figure 1E), 
titration of a Gal4-VP16-expressing plasmid resulted in a 
sigmoidal response with similar dose-response relations 
(Figure 3A). Co-expression of APP-Gal4 and Fe65 also 
resulted in a dose-response relation similar to the micro-
scopy analysis shown in Figure 2C, with saturation of the 
Cit signal at 300 ng of each plasmid (Figure 3B).
To determine if plate reader analysis would allow 
medium-throughput pharmacological screening, we 
established an in-suspension lipofection protocol. 
HEK2:UAS-Cit-NLS cells were transfected with APP-Gal4 
and Fe65 in suspension and distributed onto 48-well 
plates to ensure homogenous cell populations in different 
wells. We tested a concentration series of the γ-secretase 
inhibitor DAPT (Figure 3C). Again, increasing DAPT con-
centrations showed a dose-dependent decrease of the Cit 
signal with half-maximal inhibition at approximately 2 µm 
DAPT. Together, the plate reader analysis revealed results 
similar to those of confocal microscopy analysis of the 
UAS-Cit reporter cells.
Regulation of APP-mediated nuclear 
signaling
To test the sensitivity of our assay system, we tested APP 
mutations affecting Fe65 binding, G681A, which disrupts 
the interaction, and Y682F, which prevents tyrosine phos-
phorylation and thus enhances Fe65 binding (Figure 4A). 
Compared with the co-expression of wild-type APP-Gal4 
together with Fe65, G681A mutation nearly abolishes the 
generation of a Cit signal (Figure 4B) to levels similar to 
those observed with APP-GAL4 alone (Figure 2). In con-
trast, Y682F mutation leads to a significantly increased 
Cit signal. Representative confocal microscopy images are 
shown (Figure 4C).
We mutated several residues that have been described 
to be phosphorylated: serine and threonine to alanine and 
tyrosine to phenylalanine, to prevent phosphorylation at 
these sites. Initial experiments with lipofection of 1 µg of 
plasmid DNA did not show any difference in the Cit signal 
with different mutants except the G681A mutation that 
abolished transcriptional activity. We reduced the DNA 
concentration to 100 ng, which lies in the linear response 
range of the Gal4/UAS-Cit transcription assay. Mutation 
of S655 or Y687 resulted in a reduced Cit signal, whereas 
T668 and S675  slightly increased it (Figure 4D). The 
strongest increase in expression was again observed with 
the Y682F mutant. We performed Western blots to deter-
mine the effects of the different mutations on full-length 
APP (Figure 4E). The levels of immature and mature APP-
Gal4 for the different phosphomutants are highly similar, 
except the Y687F mutant, which presented reduced levels. 
The G681A mutation that disrupts Fe65 binding leads to a 
selective reduction of the mature APP-Gal4 band.
We previously reported that mutation of the VML 
sequence of AICD to LLR resulted in reduced AICD levels 
(Gersbacher et  al., 2013). Insertion of the LLR muta-
tion into APP-Gal4  strongly reduced induction of Cit 
Figure 3: Plate reader analysis of transcriptional activity.
(A) HEK2:UAS-Cit-NLS cells were grown in 24-well plates and 
transfected with a cDNA concentration series of Gal4-VP16. Fluorescent 
Cit signals and cell confluence measurements were acquired with a 
Tecan plate reader. Cit signals were normalized by cell confluence 
and plotted as mean ± SD. (B) Similar to A with transfection of a cDNA 
concentration series of APP-Gal4 and Fe65. (C) HEK2:UAS-Cit-NLS cells 
transfected in suspension with APP-Gal4 and Fe65 before plating on 
24-well plates. Cells were treated with a DAPT concentration series for 
20 h and measured with a plate reader as in A.
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Figure 4: Mutations in AICD reveal regulation of transcriptional activity.
(A) Human AICD amino acid sequence starting from the ε-cleavage site with mutations highlighted in red. SDS: stability-determining sequence; 
BSS: basolateral sorting signal. PTB: PTB domain binding site. (B) Confocal microscopy analysis of HEK2:UAS-Cit-NLS cells transfected with APP 
G681A and Y682F mutants together with Fe65 (7 frames imaged; bars show mean ± SD). (C) Representative confocal microscopy images from 
the experiment shown in (B). Scale bar: 200 µm. (D) Plate reader analysis of HEK2:UAS-Cit-NLS cells expressing Fe65 and APP variants with 
mutation of reported phosphorylated residues (3 wells per passage of 3 in total; bars show mean ± SD). (E) Western blot analysis of different 
the APP-Gal4 phosphomutants analyzed in (D). Anti-APP antibody detects endogenous APP and the transfected APP-Gal4. Extracts of non-
transfected HEK2:UAS-Cit-NLS (ctrl) showed signals for the immature and mature forms of endogenous APP. Signals from transfected APP-Gal4 
revealed a higher apparent molecular weight, which is likely due to the approximately additional 20 kDa of the Gal4-DBD, and superimpose 
with the – in comparison – weak signal of endogenous mature APP. (F) Confocal microscopy analysis of HEK2:UAS-Cit-NLS cells transfected with 
APP VML-LLR mutant or wt together with Fe65 (n = 6 frames per clone for every passage of a total of 3; shown is mean ± SD). (G) Representative 
confocal microscopy images from the experiment shown in (F). Scale bar: 200 µm. (H) Plate reader analysis of HEK2:UAS-Cit-NLS cells 
transfected with APP VML-LLR mutant or wt together with Fe65 (3 wells per passage of 3 in total; bars show mean ± SD).
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expression when analyzed by confocal microscopy or with 
plate reader analysis (Figure 4F, H). Representative confo-
cal microscopy images are shown (Figure 4G). These data 
clearly show that our GAL4/Cit-based assay mirrors the 
expected results of modulating APP mutations.
Discussion
We have developed a Gal4-based assay to determine POI 
transcriptional activity via expression of the fluorescent 
protein Cit. A crucial advantage is the nuclear localization 
of the reporter DNA constructs that are inserted via lentivi-
ral vectors into the genome. This ensures the detection of 
bona fide nuclear translocation. Further, the mutational 
analysis of Fe65 indicates that the assay system allows, 
aside from studying nuclear translocation, testing for tran-
scription activity properties. Stable cell lines also eliminate 
the necessity to transfect two luciferase reporter plasmids 
in addition to the POIs studied, reducing variability due to 
non-homogenous transfection ratios of plasmids in indi-
vidual cells. Furthermore, the signal can be analyzed in 
situ without cell lysis, allowing the staining and subcel-
lular localization of proteins under investigation. Readout 
is achieved by quantifying Cit fluorescence via confo-
cal microscopy or plate reader. With the evolved Cit-NLS 
reporter, confocal imaging offers accurate determination 
of Cit-NLS levels in nuclei demarcated by DAPI staining 
and thus enables analysis at the single cell level. This is 
of particular interest for combined analysis, studying 
additional cellular alterations besides nuclear transloca-
tion. We further established an in-suspension lipofection 
protocol to transfect cells before plating homogenous cell 
populations into multi-well plates. Medium-throughput 
drug screening is feasible, as we have shown for a dilution 
series of the γ-secretase inhibitor DAPT. The IC
50
 in our 
experiments is higher than reported values of 100–200 
nm that were determined with ELISAs measuring the Aβ 
generated in in vitro assays using recombinant peptides 
and cell membranes (Dovey et  al., 2001). This probably 
relates to the high sensitivity of our assay, in which, in 
living cells, a few AICD-Fe65 complexes in the nucleus are 
sufficient to drive the expression of many Cit molecules.
Titration of different transcriptional activators in 
reporter cell lines resulted in a sigmoidal increase in the 
Cit fluorescence signal, saturating at higher DNA concen-
trations. This is in contrast to the exponential increase in 
fluorescence when the fluorescent protein is expressed 
directly from a transfected plasmid. The sigmoidal 
response results from the limited number of reporter 
integrations in the nucleus that we estimated to be theo-
retically maximally 2000 if all virus particles would have 
infected the cells and integrated into the genome (see 
section ‘Results’). Thus, as single plasmids with CMV 
promoter lead to expression of hundreds to thousands of 
transcripts, expression of Cit saturates likely with trans-
fection of only very few or possibly a single plasmid.
APP is central to Alzheimer disease, with cleavage 
of this transmembrane protein by RIP generating the Aβ 
peptide and AICD (De Strooper and Annaert, 2000; Par-
dossi-Piquard and Checler, 2012). The release of AICD 
from the membrane is followed by nuclear translocation, 
together with its interacting protein Fe65 (Duilio et  al., 
1991; Kimberly et  al., 2001). In the nucleus, AICD-Fe65 
co-localizes with Tip60 in AFT spots that have proper-
ties resembling phase-separated condensates, which are 
involved in regulating transcription (von Rotz et al., 2004; 
Muller et al., 2007; Konietzko et al., 2010; Cho et al., 2018). 
Using Gal4-based luciferase assays, AICD, together with 
Fe65, was shown to have transcriptional activity (Cao and 
Sudhof, 2001). Our findings using the Gal4/UAS-Cit tran-
scription assay are in line with the published results. We 
observe a strong dependence on Fe65 co-expression that 
has also been demonstrated by other groups studying 
AICD transcriptional activity (Zambrano et al., 2004; Yang 
et al., 2006; Wiley et al., 2007).
Co-expression of APP-Gal4 with the AICD-interacting 
protein Jip1b resulted in an approximately 70% decrease 
of the Cit signal as compared to Fe65 co-expression. Previ-
ous results have shown that Jip1b promotes AICD-medi-
ated transcription differently from Fe65 (Scheinfeld et al., 
2003). The reduced transcriptional activity is also in line 
with the observation that Jip1b localizes together with 
AICD predominantly to nuclear speckles and not to the 
spots associated with transcription (von Rotz et al., 2004; 
Konietzko et  al., 2010). Co-expression of APP-Gal4  with 
the AICD-interacting protein Mint1, also known as X11, 
resulted in no increase of Cit signal as compared to expres-
sion of APP-Gal4 alone. The absent transcriptional activ-
ity is in line with the observation that Mint1 does not enter 
the nucleus and retains AICD in the cytosol (von Rotz 
et  al., 2004; Riese et  al., 2013). Likewise, in the original 
APP-Gal4 luciferase experiments as well as in experiments 
using chloramphenicol acetyl transferase reporters, Mint1 
did not support APP-Gal4-mediated transcription (Cao 
and Sudhof, 2001; Zambrano et  al., 2004). In summary, 
we observe that usage of the Gal4/UAS-Cit transcription 
assay recapitulates described properties of APP-binding 
proteins with respect to nuclear signaling.
Glycine 681 is a flexible linker in AICD that connects 
helix αN to the YENPTY motif (Radzimanowski et  al., 
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2008) and is essential for the interaction with Fe65 as 
mutation to alanine completely abolishes co-immuno-
precipitation (Cao and Sudhof, 2004). G681A mutation in 
APP-Gal4 abolished the Cit signal, even with 1 µg of APP 
and Fe65 plasmids, which is in the saturated range of 
the assay with wild-type APP. Of note, the G681A mutant 
APP also resulted in strongly reduced mature APP levels, 
pointing to a role of Fe65 in APP maturation.
When expressing Fe65 that does not contain the Gal4-
DBD without APP-Gal4 co-expression, we also could not 
detect a Cit signal. Thus, only when Gal4-AICD can bind 
Fe65 can direct it to the UAS elements to induce Cit expres-
sion. We have further observed that the position of the 
Gal4-DBD fusion strongly influences transcriptional activ-
ity. The formation of a transcriptionally active complex 
should not occlude the binding of the Gal4-DBD to the 
UAS elements and enable RNA polymerase II to be posi-
tioned correctly to initiate transcription. The dramatically 
reduced activity of the APP-Gal4ct construct, as compared 
to APP-Gal4, could be an occlusion of the C-terminal Gal4-
DBD by Fe65, which has an extended interaction inter-
face with the C-terminus of AICD (Radzimanowski et al., 
2008). Alternatively, the position of the Gal4-DBD in APP 
might affect the rate of γ-secretase cleavage, leading to an 
increase in the case of insertion after the ε-cleavage site. 
We think this is unlikely, because expression of an AICD-
Gal4ct construct together with Fe65 revealed only minor 
induction of Cit expression compared to APP-Gal4  with 
the internal Gal4-DBD (data not shown). We have reported 
that the N-terminal residues of AICD determine its turnover 
– replacing the stabilizing AICD VML sequence with LLR 
from the AL1ICD that is degraded at higher rates strongly 
reduced AICD levels (Gersbacher et al., 2013). Comparing 
an APP-Gal4 VML-LLR mutant with wild-type APP-Gal4, 
we saw a strong reduction in the Cit signal, both with con-
focal microscopy and plate reader analysis. The availabil-
ity of Gal4-AICD thus controls Cit expression by Fe65. It 
was proposed that AICD is not necessary for Fe65 to trans-
locate to the nucleus and regulate transcription (Cao and 
Sudhof, 2004). Gal4-AICD is necessary in the Gal4/UAS-Cit 
transcription assay, but this might be because of the artifi-
cial Gal4-DBD-UAS interaction. Promoters of endogenous 
target genes will be bound via a different mechanism by 
Fe65. With confocal microscopy, AICD can be seen co-
localizing with Fe65 and Tip60 in nuclear AFT spots (von 
Rotz et al., 2004; Goodger et al., 2009). Fe65 dimerizes via 
its second phosphotyrosine-binding domain (PTB), and 
binding of AICD to the Fe65 PTB2 might be necessary to 
dissolve dimerization and enable interaction with Tip60 
to target AFT spots to endogenous promoters of target 
genes (Konietzko et al., 2010).
Phosphorylation of proteins regulates their interaction 
with other proteins and is a major mechanism of signal 
transduction. We therefore studied the impact of APP phos-
phorylation sites on its nuclear signaling. All mutants were 
initially tested with 1-µg plasmid, which lies in the saturated 
range of the UAS-Cit assay and we could not detect any dif-
ference in the Cit signal compared to wild-type APP (data 
not shown) If phosphorylation only modifies signaling and 
has no on-off effect, such as the G681A mutation, which 
disrupts Fe65 binding, changes can only be detected in the 
linear range of the assay. We therefore analyzed transfec-
tions of 100-ng APP-Gal4 plasmids harboring the different 
mutations. S655 is part of the YTSI basolateral sorting signal 
in APP, and phosphorylation was shown to enhance secre-
tory trafficking and decrease lysosomal targeting (Vieira 
et  al., 2009; Vieira et  al., 2010). In line with these data, 
the APP-Gal4 S655A mutant that cannot be phosphoryl-
ated reduced the Cit reporter signal in our assay. T668 has 
been extensively studied, with conflicting results of its 
phosphorylation resulting in increased or decreased Fe65 
interaction (Ando et al., 2001; Chang et al., 2006). Analysis 
of T668A knock-in mice argued against a prominent role, 
as the mice did not show the expected deficits (Sano et al., 
2006; Barbagallo et al., 2011). The APP-Gal4 T668A mutant 
showed a slightly increased induction of the Cit signal, 
which would be an indication for reduced Fe65 interaction 
upon T668 phosphorylation. S675 has also been shown to 
be targeted by phosphorylation and acts in concert with 
T668 phosphorylation in synaptic activity-regulated Aβ 
production (Lee et al., 2017). The APP-Gal4 S675A mutant 
showed a similar increase in the Cit signal as T668A; thus, 
in our hands, these two sites both have small but signifi-
cant impact on Fe65-mediated AICD nuclear translocation.
PTB-containing proteins belong to different groups 
that are dependent or independent of tyrosine phospho-
rylation in the NPXY motif for efficient binding (Uhlik 
et al., 2005). Y682 phosphorylation is not required for Fe65 
binding (Borg et  al., 1996) or even reduces it (Tamayev 
et al., 2009; Zhou et al., 2009). Mutation of Y682 to glycine 
inhibits Fe65 binding and dramatically shifts APP pro-
cessing to the non-amyloidogenic pathway in knock-in 
mice (Barbagallo et  al., 2010). We mutated Y682 to phe-
nylalanine, which blocks phosphorylation but does not 
disrupt Fe65 binding. Consistent with the negative influ-
ence of Y682 phosphorylation of Fe65 binding, the Y682F 
mutant showed increased transcription of Cit. Mutation 
of the second tyrosine in the YENPTY motif resulted in 
reduced activity in the Gal4/UAS-Cit transcription assay. 
This can be explained by the reduced half-life of full-
length APP reported for the Y687F mutation (Rebelo 
et al., 2007), which is also evident in the low levels of this 
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mutant detected in Western blot analysis. When more APP 
is shuttled toward the lysosome, there is less available for 
nuclear signaling. The alteration in Cit transcription upon 
mutation of the studied residues also implies that they are 
under the control of phosphorylation in cells. We showed 
previously that nuclear translocation of endogenous AICD 
also occurs in primary neurons and is similarly reduced 
by γ-secretase inhibition (Goodger et al., 2009). However, 
future experiments will be required to validate the modu-
latory role of endogenous APP phosphorylation in context 
of nuclear translocation and signaling.
We have established a novel cellular assay for nuclear 
translocation. Studying nuclear signaling by APP, we 
show that the assay can detect on-off regulation of tran-
scription as well as modulatory changes of signaling by 
phosphorylation. The lentiviral reporter can be inserted 
into many cell lines or even primary cells. The Gal4/
UAS-Cit transcription assay enables the study of bona fide 
nuclear signaling in situ and will be of great utility for the 
scientific community interested in studying nuclear sign-
aling and transcriptional regulation on the cellular level 
in a quantitative manner.
Materials and methods
DNA constructs
The pUKBK expression vectors and clones of HA-Fe65, HA-X11, and 
HA-Jip1b were previously described (von Rotz et al., 2004; Kohli et al., 
2012). pSCTGal (1–93)-VP16 (Gal4-VP16) was obtained from Prof. Wal-
ter Schaffner (University of Zurich, Switzerland) and encodes the DBD 
of the yeast Gal4 protein (amino acids 1–93) fused to the C-terminal 
78 amino acids of the activation domain of the VP16 protein of the 
herpes simplex virus (Sadowski et al., 1988). The APP-Gal4 construct 
was obtained from Prof. Thomas Südhof (Stanford University, USA) 
and encodes the 695-amino acid isoform of APP with an internal 
Gal4-DBD after the ε-cleavage site preceding the basolateral sorting 
signal of AICD (Cao and Sudhof, 2001). APPGal4(VML646LLR) was 
created by side-directed mutagenesis of the APP residues valine646, 
methione647, and leucine648 to leucine, leucine, and arginine within 
the APPGal4 construct. We further inserted the APPGal4 sequence in 
the third-generation pSicoR lentivirus backbone, which was obtained 
from Prof. Ueli Suter (ETH Zurich, Switzerland) (Ventura et al., 2004). 
pUKBK-C-APP-Gal4ct encodes APP (695-amino acid isoform of human 
APP) fused at its C-terminus to the Gal4-DBD. The sequence was assem-
bled by PCR-driven overlap extension (Heckman and Pease, 2007), fol-
lowed by transfer to the pUKBK-C backbone. pCCL-9 × UAS-Cit encodes 
the fluorescence protein Cit (Griesbeck et al., 2001) under the control of 
a 9 ×  repeat of the Gal4 upstream activating sequence (UAS) motif, fol-
lowed by the adenovirus late promoter in a third-generation lentivirus 
backbone (pCCL) (Dull et al., 1998). pCCL-P-EGFP was obtained from 
Prof. Ueli Suter. The sequence was assembled by PCR-driven overlap 
extension on pGL4.35[luc2P/9 × GAL4UAS/Hygro] (Promega; Madison, 
WI, USA) and a Cit-containing vector (von Rotz et al., 2004), followed 
by transfer to the pCCL backbone. pCCL-9 × UAS-Cit-NLS was derived 
from pCCL-9 × UAS-Cit by insertion of three SV40 nuclear localiza-
tion sequences (NLS) to the C-terminus of the Cit fluorescent protein 
by PCR-driven overlap extension. The pECFP-Nuc plasmid (Takara; 
Kusatsu, Shiga, Japan) served as a template for the 3 × NLS sequence. 
Site-directed mutagenesis of pECFP-Nuc was used to create Cer-NLS 
according to the published sequence (Rizzo et  al., 2004). Exchange 
of single amino acids in the AICD of APP-Gal4-DBD sequence was 
achieved by PCR-driven overlap extension using sequence-verified 
APP clones with the respective mutations.
Cell culture, serial dilution, and lipofection
Human embryonic kidney cells (HEK293; DSMZ; Braunschweig, 
Niedersachsen, Germany) and Lenti-X cells (Takara; Kusatsu, Shiga, 
Japan) were cultured at 37°C and 5% CO
2
 in Dulbecco’s modified eagle 
medium (DMEM with glutamine and 4.5 g/l d-glucose; Thermo Fisher 
Scientific; Waltham, MA, USA), supplemented with 10% fetal bovine 
serum (FBS; Thermo Fisher Scientific; Waltham, MA, USA). For plate 
reader or microscopy experiments, HEK293  were grown in multi-
well plastic plates or on 4 well-chamber glass slides (Falcon; Corn-
ing GmbH; Kaiserslautern, Rheinland-Pfalz, Germany), successively 
coated with poly-l-ornithine (50 µg/ml; Merck; Darmstadt, Hessen, 
Germany) and fibronectin (5 µg/ml; Merck; Darmstadt,  Hessen, 
 Germany).
Plasmid DNA concentration was measured on a Nanodrop 2000 
(Thermo Fisher Scientific; Waltham, MA, USA), and 500 ng of undi-
gested DNA was routinely analyzed on agarose gels to ensure identi-
cal quality, i.e. supercoiled status that affects lipofection efficiency. 
For transfection of adherent cells, Lipofectamine 2000 (Thermo 
Fisher Scientific; Waltham, MA, USA) was used according to the 
manufacturer’s protocol. The medium was replaced after 3  h and 
cells were fixed with 4% (w/v) paraformaldehyde 20–22 h after trans-
fection. Nuclei were stained with DAPI (Merck; Darmstadt,  Hessen, 
Germany). HA-tagged constructs were stained with anti-HA high 
affinity antibodies (Merck; Darmstadt, Hessen, Germany), followed 
by anti-rat secondary antibodies labeled with Alexa647 (Jackson 
Immunoresearch; Ely, Cambridge, UK).
Pharmacological inhibition of γ-secretase
To inhibit γ-secretase, DAPT (Merck; Darmstadt, Hessen, Germany) 
was added to the medium after transfection. 8 × 106 trypsinized 
(Gibco) cells in 2 ml medium were lipofected with 600 µl Opti-MEM 
(Thermo Fisher Scientific; Waltham, MA, USA) containing 3 µg DNA of 
each clone and 15 µl Lipofectamine 2000. The suspension was incu-
bated for 1 h at 37°C with mild resuspension every 10 min. Cells were 
centrifuged, supernatant removed, resuspended in DMEM/FBS, cell 
numbers remeasured, and 3 × 105 cells plated per well on a 48-well 
plate. We performed square- and third-root serial dilutions of DAPT 
and DNA constructs, ensuring equidistance of data points on a loga-
rithmic scale. To minimize variability of lipofection for different DNA 
concentrations, we added empty expression plasmids to fill-up the 
DNA to 1 µg. To control DAPT from causing cell death at higher con-
centrations, we performed colorimetric MTT assays (Merck; Darm-
stadt, Hessen, Germany) according to the manufacturer’s protocol.
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Virus production and cell line generation
Lenti-X cells were transfected with pCCL-9 × UAS-Cit or pCCL-9 × UAS-
Cit-NLS, together with helper plasmids, by calcium phosphate 
transfection as described previously (Birnbaum et  al., 2018). Virus-
containing supernatant was sterile filtered and stored at −80°C until 
use. For generating the HEK:UAS-Cit cell line, 105 HEK293 cells were 
plated and infected the following day with 0.5  ml 9 × UAS-Cit virus 
supernatant. Further, 105 HEK293 cells were plated and infected the 
following day with 1.2 ml 9 × UAS-Cit-NLS virus supernatant yielding 
the cell line HEK1:UAS-Cit-NLS; 105 cells of this line were again infected 
with 1.2 ml virus supernatant generating line HEK2:UAS-Cit-NLS.
Western blotting
Cells were lyzed with RIPA buffer and lysates separated on Novex™ 
16% Tricine Gels (Thermo Fisher Scientific; Waltham, MA, USA). After 
transfer to 0.1 µm Amersham™ Protran™ membranes (GE Health-
care; Chicago, IL, USA), the blots were probed with anti-APP antibody 
Y188 (ab32136; Abcam; Cambridge, Cambridge, UK), anti-GAPDH 
(H86504M; Milan Analytica AG; Rheinfelden, Aargau, Switzerland) 
and anti-HA high affinity (11867423001; Roche; Basel, Basel-Stadt, 
Switzerland), followed by peroxidase-linked secondary antibodies 
(Jackson Immunoresearch; Ely, Cambridge, UK). ECL detection was 
performed with the ImageQuant LAS 4000 (GE Healthcare; Chicago, 
IL, USA) using Pierce™ ECL Western Blotting Substrate (Thermo 
Fisher Scientific; Waltham, MA, USA) or ECL Prime Western Blotting 
Detection Reagent (GE Healthcare; Chicago, IL, USA).
Plate reader analysis
Multi-well plates were analyzed with a SPARK 10  M Multimode 
Reader (Tecan; Männedorf, Zürich, Switzerland). Cit fluorescence 
was imaged with a 485/20 nm excitation and a 535/35 nm emission fil-
ter (10 flashes, 7 × 7 reads per well of 48 wells or 10 × 10 for 24 wells). 
We used the 4 ×  objective of the SPARK reader with bright-field illu-
mination to determine cell confluence. The mean value of Cit fluo-
rescence per well was normalized to cell confluence. Reporter cell 
lines without lipofection were plated in 3–6 wells to determine the 




) (Armbruster and Pry, 
2008). The LoB was subtracted from normalized Cit values, and val-
ues from experiments performed on different days with different cell 
passage numbers were normalized by sum division for comparison 
as described (Degasperi et al., 2014).
Confocal microscopy
Images were acquired on a TCS/SP8 confocal microscope (Leica; 
Wetzlar, Hessen, Germany) with a 20 ×  glycerol objective. Hybrid 
detectors (HyDs) were operated in count mode with 12-bit intensity 
resolution. DAPI was excited with a 405-nm diode laser and detected 
with a HyD window of 407–507 nm. Cit was excited with the 514-nm 
line of the argon laser and detected with a HyD window of 516–
625 nm. Cer was excited with the 458-nm line of the argon laser and 
detected with a HyD window of 460–510 nm. In this case, the HyD 
window for DAPI was set from 407 to 456 nm to prevent signal pickup 
from Cer. Alexa647  was excited with a 633-nm helium-neon laser 
and detected with a HyD window of 635–740 nm. For every experi-
ment, we initially scanned all conditions in the Cit channel visually 
via the ocular, to determine the brightest Cit fluorescence. With this 
condition, we adjusted laser intensity and accumulation number to 
avoid saturating the HyDs. We adjusted the z-position to achieve the 
brightest DAPI signal and acquired 5–7 images per condition (frame 
775 × 775 µm; ∼2000 cells). This way, the Cit channel is imaged for the 
first time during actual acquisition, preventing any bias or bleaching.
Image analysis
All image analysis was performed using Fiji/ImageJ (NIH; Bethesda, 
MD, USA). To determine the strength of transcriptional activation, we 
measured Cit or Cer integrated density (mean intensity × area) either 
over the whole frame for Cit or solely in the nucleus for Cit-NLS and 
Cer-NLS. Integrated density values were normalized by the number of 
DAPI-stained nuclei. First, a threshold that detects nearly all nuclei 
was selected for the DAPI channel. Then, the image was converted to 
mask, and the nuclei were separated using the watershed algorithm. 
The particle analyzer was applied to obtain the DAPI outlines with 
a size between 60 and 230 µm2, thus excluding small mitotic DAPI 
profiles, for example. For transactivation assays using the Cit readout, 
the total Cit/DAPI was calculated by dividing the integrated Cit over 
the whole image frame by the number of DAPI counts. The NLS-tagged 
fluorescent proteins are targeted to the nucleus and the integrated 
densities of the Cit-NLS or CER-NLS fluorescence in the DAPI outlines 
were measured, followed by dividing the sum of the integrated Cit or 
Cer densities by the number of DAPI counts. HA-tagged proteins were 
stained with anti-HA high-affinity antibody (11867423001; Roche; 
Basel, Basel-Stadt, Switzerland) and Alexa647-labeled anti-rat anti-
body (Jackson Immunoresearch; Ely, Cambridge, UK), followed by the 
measurement of total fluorescence and normalization to DAPI counts. 
Data from Fiji were transferred to Excel or Prism for further analysis.
Statistical analysis
Statistics were calculated with Prism 6 (Graph Pad; San Diego, CA, 
USA). Data were controlled for normal distribution and analyzed by 
Student’s t-test against control or wild type. Asterisks above the hori-
zontal significance line refers to all bars with ticks except when the 
ticks are marked individually (*p < 0.05, **p < 0.01, and ***p < 0.001). 
Bars not marked by a tick are not significantly different. Data are pre-
sented with average values and standard deviation (SD).
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